Loading…

S215: KEYNOTE‐667: OPEN‐LABEL, PHASE 2 STUDY OF PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY

Saved in:

Bibliographic Details
Published in:	HemaSphere 2023-08, Vol.7 (S3), p.e3506076-n/a
Main Authors:	Vinti, Luciana, Daw, Stephen, Alvarez, Constantino Sabado, Fagioli, Franca, Beishuizen, Auke, Michel, Gerard, Moleti, Maria Luisa, Cepelova, Michaela, Thorwarth, Anne, Rigaud, Charlotte, Sabando, Diego Plaza Lopez, Landman‐Parker, Judith, Shen, Juan, Pillai, Pallavi, Marinello, Patricia, Mauz‐Koerholz, Christine
Format:	Article
Language:	English
Subjects:	Oral Sessions
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!